Related references
Note: Only part of the references are listed.Estimands and their Estimators for Clinical Trials Impacted by the COVID-19 Pandemic: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions
Kelly Van Lancker et al.
STATISTICS IN BIOPHARMACEUTICAL RESEARCH (2022)
Association Between Low-Density Lipoprotein Cholesterol Levels, Statin Use, and Dementia in Patients followed in German General Practices
Rebecca Zingel et al.
JOURNAL OF ALZHEIMERS DISEASE (2021)
Trends in health expectancies: a systematic review of international evidence
Gemma F. Spiers et al.
BMJ OPEN (2021)
Trends in life expectancy and healthy life years at birth and age 65 in the UK, 2008-2016, and other countries of the EU28: An observational crosssectional study
Claire E. Welsh et al.
LANCET REGIONAL HEALTH-EUROPE (2021)
The effects of statins on microglial cells to protect against neurodegenerative disorders: A mechanistic review
Hossein Bagheri et al.
BIOFACTORS (2020)
The Safety and Tolerability of Statin Therapy in Primary Prevention in Older Adults: A Systematic Review and Meta-analysis
Zhen Zhou et al.
DRUGS & AGING (2020)
Association of Statin Use With Disability-Free Survival and Cardiovascular Disease Among Healthy Older Adults
Zhen Zhou et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials
Jordan Fulcher et al.
LANCET (2019)
Tip of the Iceberg: Assessing the Global Socioeconomic Costs of Alzheimer's Disease and Related Dementias and Strategic Implications for Stakeholders
Youssef H. El-Hayek et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Consequences of chronic diseases and other limitations associated with old age - a scoping review
Petra Maresova et al.
BMC PUBLIC HEALTH (2019)
Disability incidence and functional decline among older adults with major chronic diseases
Joelle H. Fong
BMC GERIATRICS (2019)
Quantifying Importance of Major Risk Factors for Coronary Heart Disease
Michael J. Pencina et al.
CIRCULATION (2019)
Comparing two methods for delivering clinical trial informed consent information to older adults: singular versus stepped approach
Fleur O'Hare et al.
CLINICAL TRIALS (2018)
Fourth Universal Definition of Myocardial Infarction (2018)
Kristian Thygesen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly
J. J. McNeil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Effect of Aspirin on Disability-free Survival in the Healthy Elderly
J. J. McNeil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Updated Criteria for Population-Based Stroke and Transient Ischemic Attack Incidence Studies for the 21st Century
Valery Feigin et al.
STROKE (2018)
Statins for Primary Prevention in Older Adults-Moving Toward Evidence-Based Decision-Making
Sonal Singh et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2018)
Impact of informed consent content and length on recruitment of older adults into a community based primary prevention trial
Fleur O'Hare et al.
CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS (2018)
Effect of Physical Activity on Self-Reported Disability in Older Adults: Results from the LIFE Study
Todd M. Manini et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2017)
Serum total cholesterol and risk of cardiovascular and non-cardiovascular mortality in old age: a population-based study
Yajun Liang et al.
BMC GERIATRICS (2017)
Primary Prevention With Statin Therapy in the Elderly New Meta-Analyses From the Contemporary JUPITER and HOPE-3 Randomized Trials
Paul M. Ridker et al.
CIRCULATION (2017)
Statins for Primary Prevention in Older Adults Uncertainty and the Need for More Evidence
Jerry H. Gurwitz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions A Systematic Review and Meta-analysis
Michael G. Silverman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Prevalence of frailty and disability: findings from the English Longitudinal Study of Ageing
Catharine R. Gale et al.
AGE AND AGEING (2015)
Statins in the elderly: an answered question?
Sophia Zoungas et al.
CURRENT OPINION IN CARDIOLOGY (2014)
Cochrane review on 'Statins for the treatment of dementia'
Bernadette McGuinness et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2013)
Dose-comparative effects of different statins on serum lipid levels: a network meta-analysis of 256,827 individuals in 181 randomized controlled trials
Huseyin Naci et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2013)
The Intersection Between Aging and Cardiovascular Disease
Brian J. North et al.
CIRCULATION RESEARCH (2012)
Everyone under statin?
Helene Vaillant-Roussel et al.
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2012)
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
B. Mihaylova et al.
LANCET (2012)
Human population growth and the demographic transition
John Bongaarts
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2009)
The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials
J. J. Brugts et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Prevalence of musculoskeletal pain and statin use
Catherine Buettner et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2008)
Treatment of hypertension in patients 80 years of age or older
Nigel S. Beckett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Fear of loss of independence and nursing home admission in older Australians
Susan Quine et al.
HEALTH & SOCIAL CARE IN THE COMMUNITY (2007)
Statins and the vascular endothelial inflammatory response
John Greenwood et al.
TRENDS IN IMMUNOLOGY (2007)
Epidemiology and risk factors of dementia
WM van der Flier et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Statins -: a cure-all for the brain?
T Menge et al.
NATURE REVIEWS NEUROSCIENCE (2005)
Relationship between plasma lipids and all-cause mortality in nondemented elderly
N Schupf et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)
Adverse drug reactions in elderly patients
PA Routledge et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients
M Pirmohamed et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
High-density vs low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age
AWE Weverling-Rijnsburger et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Long-term prognostic importance of total cholesterol in elderly survivors of an acute myocardial infarction: The Cooperative Cardiovascular pilot Project
JM Foody et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2003)
Prevalence, expenditures, and complications of multiple chronic conditions in the elderly
JL Wolff et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Functional disability and health care expenditures for older persons
TR Fried et al.
ARCHIVES OF INTERNAL MEDICINE (2001)
Statins: mechanism of action and effects
C Stancu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2001)
The value of serum albumin and high-density lipoprotein cholesterol in defining mortality risk in older persons with low serum cholesterol
S Volpato et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2001)
Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study
IJ Schatz et al.
LANCET (2001)
Share Paper
